16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

Term ID

CHEBI:140263

Synonyms

16-cysteinylglycinyl,17-hydroxy-4Z,7Z,10,12,14,19Z-docosahexaenoic acid
PCTR2
protectin conjugate in tissue regeneration 2
S-[(3Z,6R,7S,15Z,18Z)-21-carboxy-6-hydroxyhenicosa-3,8,10,12,15,18-hexaen-7-yl]-L-cysteinylglycine

Definition

A docosanoid that is 17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid in which a cysteinylglycinyl group is attached at position 16S via a sulfide linkage. An intermediate of specialized proresolving mediators

References

PMID:25713027

Ontology

ChEBI ( EBI )

Relationships

is a type of: dicarboxylic acid dipeptide docosanoid organic sulfide secondary alcohol

dicarboxylic acid dipeptide docosanoid organic sulfide secondary alcohol Show first 5 Terms
has_role: human xenobiotic metabolite specialised pro-resolving mediator

human xenobiotic metabolite specialised pro-resolving mediator Show first 5 Terms
inverse is_conjugate_base_of: 16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)

16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-) Show first 5 Terms
is_conjugate_acid_of: 16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)

16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-) Show first 5 Terms

Phenotype

Phenotype resulting from 16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

Phenotype where environments contain 16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

Phenotype modified by environments containing 16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

Human Disease Model